INFUSION PUMP FOR ENTERAL NUTRITION APPLIX SMART AND APPLIX VISION. Registration at Anvisa: 80145110162. 의 안전성 경고

Agência Nacional de Vigilância Sanitária (ANVISA)에 따르면, 해당 안전성 경고 는 Brazil 에서 Fresenius Kabi 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 사례 ID
    946
  • 날짜
    2008-09-03
  • 사례 국가
  • 사례 출처
    ANVISA
  • 사례 출처 URL
  • 비고 / 경고
    Brazilian data is current through June 2018. All of the data comes from Anvisa, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Brazil.
  • 데이터 추가 비고
    According to information from the company that owns the registry in Brazil, the pump has in its software functions to detect situations of occlusion of the equipment. These functions have been developed and improved since its first release. There are three versions in the following order: Version 1 (from the initial version): a function is implemented that detects downstream occlusions; Version 2 (as of May 2006, serial number 199503812): An upstream occlusion detection has been added to detect occlusions resulting from improper installations upstream of the pump (eg folded or compressed equipment, juxtaposition of the equipment or agglomeration of food, among others). This function requires a small volume to be provided to test the system's (pump and nutrition equipment) status. This volume (4ml) is supplied within the first 30 seconds after the start of pump operation. Version 3 (as of July 2007, serial number 19923272): An improved upstream occlusion detection algorithm has been implemented that allows a reduced initial volume (2ml) for low flow rates (below 50ml / h) and one volume compensation within the first hour (see details in the Instructions for Use). For more details, consult the Letter to Customers sent by the company that owns the product registration in Brazil (http://www.anvisa.gov.br/tecnovigilancia/alertas/anexos_2008/946_carta_clientes.pdf).
  • 원인
    According to information from the company holding the register, the factory unit, fresenis kabi deutschland gmbh, received two reports of digestive disorders suffered by newborns, which were induced by the initial volume generated at the initialization of the equipment due to the automatic function of occlusion detection not computer.
  • 조치
    The company informs the following actions: 1. Send letter with the relevant guidelines to evaluate the equipment to customers. 2. Add in the Instructions for Use the item "Important Remarks", an explicit illustration which demonstrates the identification of the software and the initial volume of nutrition. 3. Request in the Anvisa to change the legal information of Use Instructions / Equipment User Manual.

Manufacturer